Premier Asset Management LLC Vbi Vaccines Inc Transaction History

Premier Asset Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 12, 2021	SELL	$2.91 - $4.32 $231,170 - $343,180	-79,440 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$2.15 - $3.5 $170,796 - $278,040	79,440 New	79,440 $218,000
Q3 2020 Nov 16, 2020	SELL	$2.77 - $6.17 $93,559 - $208,397	-33,776 Closed	0 $0
Q2 2020 Jul 31, 2020	SELL	$0.87 - $3.13 $328,240 - $1.18 Million	-377,288 Reduced 91.78%	33,776 $105,000
Q1 2020 May 07, 2020	SELL	$0.73 - $1.91 $184,747 - $483,380	-253,079 Closed	0 $0
Q4 2019 Jan 23, 2020	BUY	$0.48 - $1.38 $121,477 - $349,249	253,079 New	253,079 $349,000

688K

Ticker VBIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 258,256,992
Market Cap $5.17M
Description
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...

Get notified when there are updates to the investment portfolio of Premier Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Premier Asset Management LLC with notifications on news.